Market Place
Sourcing Support
Emergent BioSolutions Appoints Dr. Simon Lowry as CMO
04 Nov 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Q3 2024 Results and Call on November 6
23 Oct 2024 //
GLOBENEWSWIRE
Emergent Demonstrates Commitment To NARCAN Access
09 Oct 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Closes $100M Asset-Backed Loan Facility
02 Oct 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Executes Contract Options For TEMBEXA
26 Sep 2024 //
GLOBENEWSWIRE
Emergent BioSolutions` mpox preparedness orders reach $400M
26 Sep 2024 //
FIERCE PHARMA
Emergent Confirms $400M In Smallpox And Mpox Orders
25 Sep 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Settles Securities Class Action Litigation
13 Sep 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Awarded $41.9M For Ebanga Ebola Treatment
12 Sep 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Refinances Debt, Strengthens Financial Profile
03 Sep 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Expands Ready To Rescue Opioid Emergency Initiative
30 Aug 2024 //
GLOBENEWSWIRE
US FDA approves Emergent`s smallpox vaccine for people at high risk of mpox
30 Aug 2024 //
REUTERS
Bora Completes Acquisition of US Sterile Fill/Finish Facility From Emergent
21 Aug 2024 //
PRESS RELEASE
Emergent joins broader efforts for mpox vaccine drive in Africa
20 Aug 2024 //
ENDPTS
Emergent BioSolutions Responds To Mpox Emergency As Cases Rise In Africa
19 Aug 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution
06 Aug 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Reports Second Quarter 2024 Financial Results
06 Aug 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Sells RSDL® Kit To SERB For $75 Million
31 Jul 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Launches Opioid Emergency Campaign With Emmitt Smith
24 Jul 2024 //
GLOBENEWSWIRE
Emergent, ex-NFL star show how to tackle opioid overdoses in new ad blitz
24 Jul 2024 //
FIERCE PHARMA
Emergent BioSolutions To Release Q2 2024 Results On August 6
23 Jul 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Extends Shelf-Life For NARCAN Spray In Canada
22 Jul 2024 //
GLOBENEWSWIRE
US FDA declines to approve Orexo`s opioid overdose drug
17 Jul 2024 //
REUTERS
Emergent BioSolutions Continues Multi-Year Transformation Plan
09 Jul 2024 //
GLOBENEWSWIRE
Emergent, J&J settle COVID vaccine supply deal dispute
08 Jul 2024 //
REUTERS
Emergent BioSolutions Awarded $250M+ For Medical Countermeasure Products
02 Jul 2024 //
GLOBENEWSWIRE
Emergent bags $250M in contract modifications to help boost US supply
02 Jul 2024 //
FIERCE PHARMA
Emergent BioSolutions Sells Baltimore-Camden Site To Bora Pharma For $30M
20 Jun 2024 //
PRESS RELEASE
Emergent Drives Progress Against Opioid Epidemic On Naloxone Day
06 Jun 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Virtual Stockholder Meeting On May 23
10 May 2024 //
GLOBENEWSWIRE
Survey Shows Need For Expanded Naloxone Access, Awareness
01 May 2024 //
GLOBENEWSWIRE
Emergent Bio Announces Strategic Operational Changes
01 May 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Reports First Quarter 2024 Financial Results
01 May 2024 //
GLOBENEWSWIRE
Emergent to cut 300 jobs, shutter 2 facilities in major overhaul
01 May 2024 //
FIERCE PHARMA
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
30 Apr 2024 //
GLOBENEWSWIRE
Emergent Bio Q1 2024 Results, Call On May 1
22 Apr 2024 //
GLOBENEWSWIRE
Emergent Continues to Awareness and Availability of NARCAN® Nasal Spray
28 Mar 2024 //
GLOBENEWSWIRE
Emergent Receives NAI Status for Baltimore Bayview Manufacturing Facility
25 Mar 2024 //
GLOBENEWSWIRE
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
06 Mar 2024 //
GLOBENEWSWIRE
Emergent Bio to Release Fourth Quarter & Full Year 2023 Financial Results
29 Feb 2024 //
GLOBENEWSWIRE
Emergent snares $235.8M US contract to supply anthrax vaccine
16 Jan 2024 //
FIERCE PHARMA
Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million
11 Jan 2024 //
GLOBENEWSWIRE
Emergent nabs US government contract of up to $235.8M for anthrax vaccine
11 Jan 2024 //
ENDPTS
Emergent Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
09 Jan 2024 //
GLOBENEWSWIRE
Emergent lines up BARDA pact to supply anthrax shot in the US
28 Nov 2023 //
FIERCE PHARMA
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
24 Nov 2023 //
GLOBENEWSWIRE
Emergent BioSolutions Reports Third Quarter 2023 Financial Results
08 Nov 2023 //
GLOBENEWSWIRE
UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results
30 Oct 2023 //
GLOBENEWSWIRE
Emergent BioSolutions to Release Third Quarter 2023 Financial Results
19 Oct 2023 //
GLOBENEWSWIRE
Emergent taps ex-NFL star to bring opioid message to tailgates
18 Oct 2023 //
FIERCE PHARMA
Emergent BioSolutions Partners with Emmitt Smith
16 Oct 2023 //
PR NEWSWIRE
Emergent Names Two Pharmaceutical Industry Veterans to Board of Directors
02 Oct 2023 //
GLOBENEWSWIRE
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making
30 Aug 2023 //
GLOBENEWSWIRE
Emergent BioSolutions to lay off about 400 employees
09 Aug 2023 //
REUTERS
Emergent BioSolutions Announces Strategic Steps to Strengthen Financial Position
08 Aug 2023 //
GLOBENEWSWIRE
Emergent BioSolutions Reports Financial Results for Second Quarter 2023
08 Aug 2023 //
GLOBENEWSWIRE
BARDA awards Emergent 10-year, $704M contract for Ebola treatment
01 Aug 2023 //
ENDPTS
Emergent Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704M
31 Jul 2023 //
GLOBENEWSWIRE
Emergent BioSolutions to Release Second Quarter 2023 Financial Results
25 Jul 2023 //
GLOBENEWSWIRE
US FDA approves Emergent BioSolutions` anthrax vaccine
21 Jul 2023 //
REUTERS
